Publicaciones (133) Publicaciones de JOSÉ BARBERÁN LÓPEZ

2024

  1. Guía de recomendaciones para la prevención de la infección sociosanitaria en las residencias de mayores

    Farmacéuticos comunitarios, Vol. 16, Núm. 1, pp. 28-50

2023

  1. Antimicrobial resistance in Gram-negative bacilli in Spain: an experts’ view

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 65-81

  2. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  3. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

  4. Recommendations for the prevention of healthcare-associated infections in nursing homes

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 552-561

  5. Recommendations on the use of azole antifungals in hematology-oncology patients

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 3, pp. 236-258

2022

  1. Analysis of Prior Aspirin Treatment on in-Hospital Outcome of Geriatric COVID-19 Infected Patients

    Medicina (Kaunas, Lithuania), Vol. 58, Núm. 11

  2. Decalogue for the selection of oral antibiotics for lower respiratory tract infections

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 16-29

  3. Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 357-361

  4. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  5. Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

    Life science alliance, Vol. 5, Núm. 4

2021

  1. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  2. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

2020

  1. Development of a predictive model for hospital mortality and re-admission in a cohort of infected patients that require hospitalization

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 5, pp. 350-357

  2. Recommendations for the diagnosis and treatment of clostridioides difficile infection: An official clinical practice guideline of the spanish society of chemotherapy (SEQ), spanish society of internal medicine (SEMI) and the working group of postoperative infection of the spanish society of anesthesia and reanimation (SEDAR)

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 2, pp. 151-175

  3. Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: Attitude in different clinical settings

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 6, pp. 466-484

2019

  1. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

    The Lancet Respiratory Medicine, Vol. 7, Núm. 11, pp. 951-963

  2. New perspectives for reassessing fosfomycin: applicability in current clinical practice

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 32, pp. 1-7

  3. Three keys to the appropriate choice of oral antibiotic treatment in the respiratory tract infections

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 6, pp. 497-515

2018

  1. Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100